Sun Pharma’s arm raises Rs 1,000 crore on private placement basis

24 Dec 2015 Evaluate

Sun Pharmaceutical Industries’ wholly-owned subsidiary - Sun Pharma Laboratories has raised, on private placement basis, Rs 1,000 crore by allotment of 10,000,  ‘AAA / Stable Outlook’ Rated by ICRA, Unsecured Redeemable Non-Convertible Debentures of a face value of Rs 10,00,000 each to be listed on BSE under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 39 months.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.


Sun Pharma Inds. Share Price

1611.90 -27.40 (-1.67%)
28-Jan-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1611.90
Dr. Reddys Lab 1224.10
Cipla 1315.80
Zydus Lifesciences 889.30
Lupin 2126.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×